DE3883658T2 - Peptide. - Google Patents

Peptide.

Info

Publication number
DE3883658T2
DE3883658T2 DE88306696T DE3883658T DE3883658T2 DE 3883658 T2 DE3883658 T2 DE 3883658T2 DE 88306696 T DE88306696 T DE 88306696T DE 3883658 T DE3883658 T DE 3883658T DE 3883658 T2 DE3883658 T2 DE 3883658T2
Authority
DE
Germany
Prior art keywords
residue
methylamino
amino
methyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88306696T
Other languages
English (en)
Other versions
DE3883658D1 (de
Inventor
Ian James Galpin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of DE3883658D1 publication Critical patent/DE3883658D1/de
Application granted granted Critical
Publication of DE3883658T2 publication Critical patent/DE3883658T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE88306696T 1987-07-22 1988-07-21 Peptide. Expired - Fee Related DE3883658T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878717299A GB8717299D0 (en) 1987-07-22 1987-07-22 Peptides

Publications (2)

Publication Number Publication Date
DE3883658D1 DE3883658D1 (de) 1993-10-07
DE3883658T2 true DE3883658T2 (de) 1994-01-05

Family

ID=10621085

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88306696T Expired - Fee Related DE3883658T2 (de) 1987-07-22 1988-07-21 Peptide.

Country Status (6)

Country Link
US (1) US4997648A (de)
EP (1) EP0300784B1 (de)
JP (1) JPH01151598A (de)
AT (1) ATE93864T1 (de)
DE (1) DE3883658T2 (de)
GB (2) GB8717299D0 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5362629A (en) * 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DK0991660T3 (da) 1997-10-08 2006-02-13 Isotechnika Inc Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler
JP2003056266A (ja) * 2001-08-15 2003-02-26 Kawajun Co Ltd 固定車輪付き折り畳み脚立
PL210841B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny izomerów (E) i (Z) ISATX247
NZ594755A (en) 2009-01-30 2013-12-20 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
WO2012145427A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
RU2014114996A (ru) * 2011-09-28 2015-11-10 Нозофарм Новые пептидные производные в качестве антибиотиков
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
AU2014311346A1 (en) 2013-08-26 2016-03-17 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C
WO2016073480A1 (en) 2014-11-03 2016-05-12 Enanta Pharmaceuticals, Inc. Novel cyclosporin analogues for preventing or treating hepatitis c infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (de) * 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
GB8303994D0 (en) * 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials

Also Published As

Publication number Publication date
DE3883658D1 (de) 1993-10-07
EP0300784B1 (de) 1993-09-01
GB2207433A (en) 1989-02-01
GB8817433D0 (en) 1988-08-24
GB8717299D0 (en) 1987-08-26
JPH01151598A (ja) 1989-06-14
GB2207433B (en) 1990-10-10
ATE93864T1 (de) 1993-09-15
US4997648A (en) 1991-03-05
EP0300784A2 (de) 1989-01-25
EP0300784A3 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
ATE93864T1 (de) Peptide.
DE3885959D1 (de) Cyclosporine.
EP0871654A4 (de) Protegrine
HUP0000577A2 (hu) Heptapeptid oxitocin analogók, e vegyületeket tartalmazó gyógyászati készítmények,továbbá eljárás előállításukra,valamint e vegyületek alkalmazása
EP0711305A4 (de) Protegrine
HUP9802372A2 (hu) Szomatosztatin gyűrűs peptid analógjai
CA2097192A1 (en) Bombesin antagonists
DE60144561D1 (de) N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide
AU551892B2 (en) Gnrh antagonists
EP0297456A3 (de) Immunsuppressive Peptide
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
CA2086243A1 (en) Anticoagulant peptides
GB1489326A (en) Pharmaceutically active polypeptides
GB992957A (en) New decapeptides and their manufacture
AU2002212623A1 (en) Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
ES416516A1 (es) Un procedimiento para la preparacion de nonapeptidos.
KR870007206A (ko) 폴리펩타이드 화합물
KR970701732A (ko) 펩신 방출을 억제하기 위한 펩티드(Peptides Inhibiting the Release of Pepsin)
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина
ATE17585T1 (de) Peptide.
NO931745L (no) Stabiliserte, sterkt virkende grf-analoger
KR920018074A (ko) 사이클릭 항-응집성 펩티드
GB1524319A (en) Polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee